Kumiko Kagawa

Tokushima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

PTHrP-producing diffuse large B-cell lymphoma presenting with hypercalcemia at diagnosis

PTHrP-producing diffuse large B-cell lymphoma presenting with hypercalcemia at diagnosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 13, 2026

Marked Platelet Clumping and Giant Platelets due to GP Ib/IX Autoantibodies.

Marked Platelet Clumping and Giant Platelets due to GP Ib/IX Autoantibodies.

Journal: American journal of hematology

Published: September 12, 2025

Hemostatic therapy for hemorrhagic cholecystitis in a patient with hemophilia A with inhibitors

Hemostatic therapy for hemorrhagic cholecystitis in a patient with hemophilia A with inhibitors

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: June 04, 2025

Acute myeloid leukemia developed through myeloproliferative features during immunosuppressive therapy for juvenile idiopathic arthritis.

Acute myeloid leukemia developed through myeloproliferative features during immunosuppressive therapy for juvenile idiopathic arthritis.

Journal: The journal of medical investigation : JMI

Published: October 27, 2024

Multiple myeloma with t (8;14) and t (11;14) and extramedullary infiltration of multiple organs

Multiple myeloma with t (8;14) and t (11;14) and extramedullary infiltration of multiple organs

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: July 03, 2024

Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction.

Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction.

Journal: Cancer science

Published: June 04, 2024

Skeletal muscle mass during chemotherapy for haematological malignancies: a retrospective study.

Skeletal muscle mass during chemotherapy for haematological malignancies: a retrospective study.

Journal: BMJ supportive & palliative care

Published: March 06, 2024

Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.

Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.

Journal: International journal of hematology

Published: August 12, 2023

Successful treatment of traumatic intramuscular hemorrhage with coagulation factor VIII replacement in a patient with congenital hemophilia A with decreased inhibitor activity by emicizumab therapy

Successful treatment of traumatic intramuscular hemorrhage with coagulation factor VIII replacement in a patient with congenital hemophilia A with decreased inhibitor activity by emicizumab therapy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: April 05, 2023

Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice.

Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice.

Journal: International journal of hematology

Published: November 08, 2022

Constitutional pericentric inversion of chromosome 16, inv(16)(p13.1q22), mimicking acute myeloid leukemia.

Constitutional pericentric inversion of chromosome 16, inv(16)(p13.1q22), mimicking acute myeloid leukemia.

Journal: EJHaem

Published: September 02, 2022

Clinical features of five cases of acquired factor V deficiency

Clinical features of five cases of acquired factor V deficiency

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 04, 2022

Showing 1-12 of 57

Last Updated: 09/26/2026